Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.238,85
-0,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ XORTX Therapeutics Inc (XRTX) XORTX Therapeutics Inc (XRTX) Notizie

XORTX Therapeutics Inc

XRTX
2,93
0,34 (13,13%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202413:00GLOBEXORTX Announces Publication of Key Research in ADPKD
08/4/202413:30GLOBEXORTX Welcomes New Member to the Board of Directors
08/4/202413:00GLOBEXORTX Announces Participation in Spring 2024 Investor..
27/3/202410:00GLOBEXORTX Announces New Clinical Advisory Board Member
19/3/202410:00GLOBEXORTX Highlights Achievements of 2023 and Preparation for..
11/3/202412:00GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
04/3/202413:00GLOBEXORTX Finalizes $2.7 Million Prospectus Supplement and..
15/2/202413:00GLOBEXORTX Raises $2.5 Million Under Prospectus Supplement and..
02/2/202402:46GLOBEXORTX Files an Amended and Restated Prospectus Supplement..
15/1/202413:00GLOBEXORTX Announces $2 Million Public Offering
03/1/202413:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202413:00GLOBEXORTX Submits a New Patent for the Treatment of Chronic..
02/1/202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202413:00GLOBEXORTX Welcomes New Member to the Board of Directors
30/11/202322:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202313:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202313:30GLOBEXORTX Announces US ATM Offering
30/11/202303:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202313:00GLOBEXORTX Meets Nasdaq Continued Listing Requirements
13/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/11/202313:00GLOBEXORTX Clarifies Timing for Share Consolidation
08/11/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202323:00GLOBEXORTX Announces Share Consolidation
02/11/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202312:00GLOBEXORTX Sponsored Study Presented at the American Society of..
27/10/202323:30GLOBEXORTX Announces Results of Special Meeting of Shareholders
25/10/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202323:00GLOBEXORTX Announces Date for Rescheduled Special Meeting of..
25/10/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202313:00GLOBEXORTX Announces Rescheduling of Special Meeting of..
12/10/202313:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/10/202313:00GLOBEXORTX Reports that Independent Proxy Firm, ISS, Recommends..
04/10/202319:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202313:00GLOBEXORTX Calls Special Meeting of Shareholders
28/9/202313:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202313:00GLOBEXORTX Sponsored Study Selected for Presentation at the..
12/9/202321:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202313:00GLOBEXORTX Announces Participation at Upcoming Investor..
07/9/202314:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/9/202313:00GLOBEXORTX Joins the Kidney Foundation and Kidney March
29/8/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202313:00GLOBEXORTX Submits Orphan Drug Designation Application to the..
25/8/202312:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202322:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202322:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
04/8/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/8/202323:00GLOBEXORTX Appoints Chief Financial Officer
Apertura: 2,75 Min: 2,5301 Max: 3,00
Chiusura: 2,59

La tua Cronologia

NASDAQ
XRTX
XORTX Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network